The biological mechanisms driving these temporal variations in biofluid markers remain unexplained but are consistent with predominantly neuronal damage occurring in premanifest/early stages of HD [18], versus progressive glial dysfunction and abnormal tau accumulation in later stages. This evidence concerns the gene MAPT and Huntington disease.